Your browser doesn't support javascript.
loading
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Cavallari, Larisa H; Lee, Craig R; Beitelshees, Amber L; Cooper-DeHoff, Rhonda M; Duarte, Julio D; Voora, Deepak; Kimmel, Stephen E; McDonough, Caitrin W; Gong, Yan; Dave, Chintan V; Pratt, Victoria M; Alestock, Tameka D; Anderson, R David; Alsip, Jorge; Ardati, Amer K; Brott, Brigitta C; Brown, Lawrence; Chumnumwat, Supatat; Clare-Salzler, Michael J; Coons, James C; Denny, Joshua C; Dillon, Chrisly; Elsey, Amanda R; Hamadeh, Issam S; Harada, Shuko; Hillegass, William B; Hines, Lindsay; Horenstein, Richard B; Howell, Lucius A; Jeng, Linda J B; Kelemen, Mark D; Lee, Yee Ming; Magvanjav, Oyunbileg; Montasser, May; Nelson, David R; Nutescu, Edith A; Nwaba, Devon C; Pakyz, Ruth E; Palmer, Kathleen; Peterson, Josh F; Pollin, Toni I; Quinn, Alison H; Robinson, Shawn W; Schub, Jamie; Skaar, Todd C; Smith, D Max; Sriramoju, Vindhya B; Starostik, Petr; Stys, Tomasz P; Stevenson, James M.
Afiliação
  • Cavallari LH; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida. Electronic address: lcavallari@cop.ufl.edu.
  • Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy and McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Beitelshees AL; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Cooper-DeHoff RM; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida; Department of Medicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida.
  • Duarte JD; Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
  • Voora D; Department of Medicine, Center for Applied Genomics & Precision Medicine, Duke University, Durham, North Carolina.
  • Kimmel SE; University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
  • McDonough CW; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida.
  • Gong Y; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida.
  • Dave CV; Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, Florida.
  • Pratt VM; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana.
  • Alestock TD; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Anderson RD; Department of Medicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida.
  • Alsip J; Division of Cardiovascular Sciences, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Ardati AK; Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, Illinois.
  • Brott BC; Division of Cardiovascular Sciences, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Brown L; Veterans Administration Medical Center, Baltimore, Maryland.
  • Chumnumwat S; Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
  • Clare-Salzler MJ; Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida.
  • Coons JC; Department of Pharmacy and Therapeutics, Center for Clinical Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.
  • Denny JC; Departments of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Dillon C; Department of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Elsey AR; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida.
  • Hamadeh IS; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida.
  • Harada S; Department of Pathology and Hugh Kaul Personalized Medicine Institute, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Hillegass WB; Heart South Cardiovascular Group, Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.
  • Hines L; Department of Neuropsychology, University of North Dakota, Fargo, North Dakota.
  • Horenstein RB; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Howell LA; Division of Cardiology and McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Jeng LJB; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Kelemen MD; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Lee YM; Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
  • Magvanjav O; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida.
  • Montasser M; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Nelson DR; College of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida.
  • Nutescu EA; Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois; Department of Pharmacy Systems, Outcomes and Policy and Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
  • Nwaba DC; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Pakyz RE; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Palmer K; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Peterson JF; Departments of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Pollin TI; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Quinn AH; Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
  • Robinson SW; Department of Medicine, University of Maryland, Baltimore, Maryland; Veterans Administration Medical Center, Baltimore, Maryland.
  • Schub J; Department of Medicine, University of Maryland, Baltimore, Maryland.
  • Skaar TC; Department of Medicine, Krannert Institute of Cardiology & Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Smith DM; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida.
  • Sriramoju VB; Division of Cardiology and McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Starostik P; Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida.
  • Stys TP; Department of Medicine, University of South Dakota, Sanford School of Medicine, Sioux Falls, South Dakota.
  • Stevenson JM; Department of Pharmacy and Therapeutics, Center for Clinical Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.
JACC Cardiovasc Interv ; 11(2): 181-191, 2018 01 22.
Article em En | MEDLINE | ID: mdl-29102571
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Intervenção Coronária Percutânea / Citocromo P-450 CYP2C19 / Cloridrato de Prasugrel / Testes Farmacogenômicos / Variantes Farmacogenômicos / Clopidogrel / Ticagrelor Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JACC Cardiovasc Interv Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Intervenção Coronária Percutânea / Citocromo P-450 CYP2C19 / Cloridrato de Prasugrel / Testes Farmacogenômicos / Variantes Farmacogenômicos / Clopidogrel / Ticagrelor Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JACC Cardiovasc Interv Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2018 Tipo de documento: Article